✦ LIBER ✦

O-1 A phase III trial comparing weekly and three weekly docetaxel in second line treatment of patients with advanced non small cell lung cancer (NSCLC)

✍ Scribed by Schuette, Wolfgang; Nagel, Sylke; Lautenschlaeger, C.; Serke, Monika; Wollschlaeger, Bettina

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of weekly docetaxel (D) i

✍ Lilenbaum, R; Schwartz, M; Siegel, L; Belette, F; Blaustein, A; Wittlin, F; Cisn 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

P-551 A phase II randomized trial of wee

✍ Tsai, Chun-Ming; Chiu, Chao-Hua; Wang, Gwo-Shu; Su, Wei-Juin; Chen, Yuh-Min; Per 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 342 KB

Second line treatment of antiangiogenic

✍ Stani, Simonetta Chiara; Sarmiento, Roberta; Mansueto, Giovanni; Bonginelli, Pao 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Phase II trial of weekly docetaxel and g

✍ Sujith Kalmadi; Giles McNeill; Mellar Davis; David Peereboom; David Adelstein; T 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 68 KB

O-2 TWO second-line docetaxel dose-sched

✍ Camps, Carlos; Massuti, Bartomeu; Jimenez, Ana Maria; Batista, Noberto; Galan, A 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 188 KB

P-230 A phase II study of weekly docetax

✍ Han, Ji-Youn; Lee, Dae Ho; Kim, Hae Young; Chun, Jong Ho; Yoon, Sung Min; Lee, H 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB